Table 3 Protein regulators of the four selected miRs.
miR symbol | upstream regulators | References |
---|---|---|
hsa-miR-92a-3p | E2F, C Myc-↑ | Oncotarget; 2020, 39: 6529–43 |
hsa-miR-128-3p | HIF-1α- ↑ | Aging (Albany NY) 2020, 12: 4067–81 Cancer Res. 2012, 72: 6036–50 |
Snail- ↑ | Oncotarget 2017, 8: 39,280–39,295 | |
P53R 175H- ↑ | Carcinogenesis, 2010, 31: 1045–1053 | |
hsa-miR-342-3p | HER2Δ16- ↑ | Mol Cancer 2010, 9:317 |
EVL (Ena/VASP-like)- ↑ | Scientific Reports 2018, 8:12,252 | |
Estrogen Receptor (ER)- ↑ | Asian Pac J Cancer Prev 2012, 13: 873–7 | |
hsa-miR-125b-1-3p | by CDX2, ↑ | Summarized in: Leukemia; 2012, 26: 2011–18 |
NF-κβ, P53 ↑ or↓ | PLoS One 2011, 6: e17169 | |
Cell Cycle 2007, 6: 1586–93 | ||
by MYC and AKT1 ↓ | Nat Genet 2008, 40: 43–50 | |
C/EBPa- ↑ | Immunity 2009, 31: 220–31 | |
Era- ↑ | Leukemia 2015, 29: 2402 – 2448 | |
Nrf2- ↑ | J. Hepatol. 2015, 63: 1466–75 | |
 | Cell Death Differ 2015, 4: 654–64 |